Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Complications of Alborz Daroo enoxaparin vs Clexane in acute coronary syndrome
IRCT2015090821979N2Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of enoxaparin in acute coronary syndrome (ACS), myocardial infarction (MI), Non-ST-segment elevation myocardial infarction (NSTEMI) and 1 more (2 arms), sponsored by Shahroud University of Medical Sciences. Started Sep 2015; status: completed.
02
Drugs
enoxaparin
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)Non-ST-segment elevation myocardial infarction (NSTEMI)unstable angina
Beyond the preview
Go deeper on IRCT2015090821979N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015090821979N2.